
    
      This is a 12-week, double blind, placebo controlled study to evaluate the efficacy of
      gabapentin in treating outpatients with cannabis dependence. After an initial phone screen, a
      comprehensive screening visit is scheduled to determine eligibility. Upon enrollment,
      counseling, medication dispensation and research assessments occur 1 time per week for 3
      months.
    
  